Co-Authors
This is a "connection" page, showing publications co-authored by Thomas Dix and Russell Norris.
Connection Strength
0.691
-
Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules. 2022 Jun 08; 27(12).
Score: 0.211
-
Biased Opioid Receptor Ligands: Gain without Pain. Trends Endocrinol Metab. 2020 11; 31(11):801-802.
Score: 0.187
-
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine. Front Pharmacol. 2020; 11:1253.
Score: 0.186
-
Developmental basis for filamin-A-associated myxomatous mitral valve disease. Cardiovasc Res. 2012 Oct 01; 96(1):109-19.
Score: 0.106